BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Chronic myeloid leukemia (CML) is a typical stem cell disorder characterized by the formation of the fusion protein—tyrosine kinase BCR-ABL in hematopoietic stem cells (HSCs), which leads to the malignant transition of HSCs to leukemic stem cells (LSCs)1.